These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8400616)

  • 1. Chemical synthesis of an O-phosphorylated tyrosine analogue of human angiotensin II, [Tyr(P)4] angiotensin II, and its vasoconstrictor effect in intact sheep.
    Kitas EA; Johns RB; May CN; Tregear GW; Wade JD
    Pept Res; 1993; 6(4):205-10. PubMed ID: 8400616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiotensin II in the pressor response to cortisol in fetal sheep during late gestation.
    Forhead AJ; Fowden AL
    Exp Physiol; 2004 May; 89(3):323-9. PubMed ID: 15123568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of elevated renin substrate on angiotensin II and arterial blood pressure in conscious mice.
    Cholewa BC; Mattson DL
    Exp Physiol; 2005 Jul; 90(4):607-12. PubMed ID: 15833753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis and analysis of cyclic analogs of angiotensin].
    Antsans IuE; Bisenietse DA; Vosekalna IA; Myshliakova NV; Chipens GI
    Bioorg Khim; 1990 Mar; 16(3):358-69. PubMed ID: 2357239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and biological activity of cyclic analogs of angiotensin].
    Bisenietse DA; Antsans IuE; Myshliakova NV; Kublik GG; Porunkevich EA
    Bioorg Khim; 1987 Feb; 13(2):149-59. PubMed ID: 2437929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive effect of angiotensin II after AT1-receptor blockade with losartan.
    Matys T; Pawlak R; Kucharewicz I; Chabielska E; Buczko W
    J Physiol Pharmacol; 2000 Mar; 51(1):161-6. PubMed ID: 10768859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain C-FOS expression and pressor responses after I.V. or I.C.V. angiotensin in the near-term ovine fetus.
    Shi L; Yao J; Stewart L; Xu Z
    Neuroscience; 2004; 126(4):979-87. PubMed ID: 15207331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
    Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
    Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of angiotensin-II on lipolysis in humans.
    Townsend RR
    Metabolism; 2001 Apr; 50(4):468-72. PubMed ID: 11288044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of [1-Aib]-angiotensin II, an analogue with higher potency than [1-Asn,5-Val]-angiotensin II.
    Cordopatis P; Theodoropoulos D
    Experientia; 1983 Jan; 39(1):106-8. PubMed ID: 6825770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic screening for bioactive peptides.
    Maeji NJ; Bray AM; Valerio RM; Seldon MA; Wang JX; Geysen HM
    Pept Res; 1991; 4(3):142-6. PubMed ID: 1726649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological properties of [1-N4-dimethyl-asparagine]-angiotensin II.
    Cordopatis P; Brison J; Dirkx J; Theodoropoulos D
    Experientia; 1979 Jul; 35(7):849-50. PubMed ID: 477828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and specific pressor activity of [1-aspartic acid,5-valine,9-serine]angiotensin I ("fowl angiotensin I").
    Hayashi Y; Nakajima T; Watanabe TX; Sokabe H; Khosla MC; Bumpus FM
    J Med Chem; 1977 Feb; 20(2):315-6. PubMed ID: 836506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral production of angiotensin II and III in sheep.
    Fei DT; Coghlan JP; Fernley RT; Scoggins BA; Tregear GW
    Circ Res; 1980 Jun; 46(6 Pt 2):I135-7. PubMed ID: 7379257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of angiotensin II analogues by incorporating beta-homotyrosine or beta-homoisoleucine residues.
    Stachowiak K; Khosla MC; Plucinska K; Khairallah PA; Bumpus FM
    J Med Chem; 1979 Sep; 22(9):1128-30. PubMed ID: 490561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.
    Johannesson P; Erdélyi M; Lindeberg G; Frändberg PA; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2004 Nov; 47(24):6009-19. PubMed ID: 15537355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of [alpha-methyltyrosine-4]angiotensin II: studies of its conformation, pressor activity, and mode of enzymatic degradation.
    Khosla MC; Stachowiak K; Smeby RR; Bumpus FM; Piriou F; Lintner K; Fermandjian S
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):757-60. PubMed ID: 6940144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.